Valeritas (NSDQ:VLRX) said today that its wearable insulin delivery device has launched in Italy.
The Bridgewater, N.J.-based company inked an exclusive distribution deal with Movi SpA to bring its V-Go device to the more than 2 million people in Italy with Type 2 diabetes.
Get the full story at our sister site, Drug Delivery Business News.
The post Valeritas launches wearable insulin delivery device in Italy appeared first on MassDevice.